
A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification
Keywords: دی هیدروپیریمیدین دی هیدروژناز; Irinotecan; Dose intensification; 5-Fluorouracil dose adaptation; Dihydropyrimidine deshydrogenase; DPD;